Zacks Investment Research on MSN
UiPath, Inc. (PATH) is attracting investor attention: Here is what you should know
UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
UiPath Inc. shares were on track for their worst daily drop on record after the automation-software company’s latest earnings marked a twist on the industry’s well-established doldrums. Software ...
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic ...
We recently published 10 Stocks Sparking Massive Fortunes. UiPath Inc. (NYSE:PATH) is one of the best performers on Friday. UiPath soared 34.7 percent week-on-week to hit a 19-month high, as investors ...
UiPath aims to lead the RPA market by integrating advanced AI solutions, differentiating itself from competitors like Automation Anywhere and Blue Prism. Strategic partnerships with tech giants like ...
Zacks Investment Research on MSN
UiPath (PATH) is a great momentum stock: Should you buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
UiPath, Inc. (NYSE:PATH) reported its fourth-quarter financial results after the bell Wednesday. Here's a look at the highlights. The company reported quarterly earnings of 22 cents per share which ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果